4.7 Review

Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome

Journal

Publisher

MDPI
DOI: 10.3390/ijms19092508

Keywords

adjuvant-induced arthritis; arthritis; celastrol; curcumin; dietary supplements; EGCG; green tea; inflammation; liposomes; microbiome; nanoparticles; natural products; resveratrol; rheumatoid arthritis; targeted delivery; traditional medicine; Tripterygium wilfordii; triptolide

Funding

  1. National Institutes of Health, Bethesda, MD, USA [R01 AT004321, F31 AT009421, R24 AT001293, P01 AT002605]
  2. United States (U.S.) Department of Veterans Affairs (Biomedical Laboratory Research and Development Service) [5 I01 BX002424]
  3. NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER
  4. NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P01AT002605] Funding Source: NIH RePORTER
  5. National Center for Complementary & Integrative Health [R24AT001293, F31AT009421] Funding Source: NIH RePORTER
  6. Veterans Affairs [I01BX002424] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Rheumatoid arthritis (RA) is a chronic, debilitating illness characterized by painful swelling of the joints, inflammation of the synovial lining of the joints, and damage to cartilage and bone. Several anti-inflammatory and disease-modifying drugs are available for RA therapy. However, the prolonged use of these drugs is associated with severe side effects. Furthermore, these drugs are effective only in a proportion of RA patients. Hence, there is a need to search for new therapeutic agents that are effective yet safe. Interestingly, a variety of herbs and other natural products offer a vast resource for such anti-arthritic agents. We discuss here the basic features of RA pathogenesis; the commonly used animal models of RA; the mainstream drugs used for RA; the use of well-characterized natural products possessing anti-arthritic activity; the application of nanoparticles for efficient delivery of such products; and the interplay between dietary products and the host microbiome for maintenance of health and disease induction. We believe that with several advances in the past decade in the characterization and functional studies of natural products, the stage is set for widespread clinical testing and/or use of these products for the treatment of RA and other diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available